{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:16:42Z","timestamp":1778894202351,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1097\/md.0000000000004451","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T22:42:55Z","timestamp":1472683375000},"page":"e4451","source":"Crossref","is-referenced-by-count":17,"title":["Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer"],"prefix":"10.1097","volume":"95","author":[{"given":"Tianpeng","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaowei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Upadhyaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R2-13-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R3-13-20210226","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/jc.2007-1154","article-title":"The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer","volume":"93","author":"Brown","year":"2008","journal-title":"J Clin Endocrinol Metabol"},{"key":"R4-13-20210226","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/sj.bjc.6601319","article-title":"Second primary malignancies in thyroid cancer patients","volume":"89","author":"Rubino","year":"2003","journal-title":"Br J Cancer"},{"key":"R5-13-20210226","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MNM.0000000000000419","article-title":"Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis","volume":"37","author":"Zhang","year":"2016","journal-title":"Nucl Med Commun"},{"key":"R6-13-20210226","first-page":"1551","article-title":"Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma","volume":"39","author":"Alexander","year":"1998","journal-title":"J Nucl Med"},{"key":"R7-13-20210226","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/thy.2008.0430","article-title":"Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation","volume":"19","author":"Molinaro","year":"2009","journal-title":"Thyroid"},{"key":"R8-13-20210226","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1210\/jc.2002-020210","article-title":"Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma","volume":"87","author":"Kloos","year":"2002","journal-title":"J Clin Endocrinol Metabol"},{"key":"R9-13-20210226","first-page":"1549","article-title":"Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer","volume":"45","author":"de Keizer","year":"2004","journal-title":"J Nucl Med"},{"key":"R10-13-20210226","first-page":"85","article-title":"Hematologic changes observed following I-131 therapy for thyroid carcinoma","volume":"4","author":"Haynie","year":"1963","journal-title":"J Nucl Med"},{"key":"R11-13-20210226","first-page":"464","article-title":"Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. I. Peripheral blood changes","volume":"163","author":"Schober","year":"1987","journal-title":"Strahlenther Onkol"},{"key":"R12-13-20210226","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2967\/jnumed.107.049072","article-title":"Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal","volume":"49","author":"Tuttle","year":"2008","journal-title":"J Nucl Med"},{"key":"R13-13-20210226","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/MNM.0000000000000132","article-title":"Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma","volume":"35","author":"Fard-Esfahani","year":"2014","journal-title":"Nucl Med Commun"},{"key":"R14-13-20210226","first-page":"171","article-title":"The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer","volume":"87","author":"Benua","year":"1962","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"R15-13-20210226","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1210\/jc.2015-2124","article-title":"Bone marrow function after (131)I therapy in patients with differentiated thyroid carcinoma","volume":"100","author":"Prinsen","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"R16-13-20210226","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4158\/EP13172.OR","article-title":"Complete blood counts are frequently abnormal 1 year after dosimetry-guided radioactive iodine therapy for metastatic thyroid cancer","volume":"20","author":"Padovani","year":"2014","journal-title":"Endocr Pract"},{"key":"R17-13-20210226","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/ki.1974.119","article-title":"The thyroid and the kidney","volume":"6","author":"Bradley","year":"1974","journal-title":"Kidney Int"},{"key":"R18-13-20210226","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jcem-21-5-548","article-title":"Kidney function in various thyroid states","volume":"21","author":"Ford","year":"1961","journal-title":"J Clin Endocrinol Metabol"},{"key":"R19-13-20210226","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1210\/jcem-14-12-1539","article-title":"Renal function and I131 clearance in hyperthyroidism and myxedema","volume":"14","author":"Hlad","year":"1954","journal-title":"J Clin Endocrinol Metabol"},{"key":"R20-13-20210226","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"R21-13-20210226","first-page":"648","article-title":"Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective International Controlled Study of Ablation after rhTSH or hormone withdrawal","volume":"47","author":"Hanscheid","year":"2006","journal-title":"J Nucl Med"},{"key":"R22-13-20210226","first-page":"1065","article-title":"rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I","volume":"44","author":"Menzel","year":"2003","journal-title":"J Nucl Med"},{"key":"R23-13-20210226","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.2967\/jnumed.108.050591","article-title":"Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity","volume":"49","author":"Rosario","year":"2008","journal-title":"J Nucl Med"},{"key":"R24-13-20210226","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00259-008-1046-0","article-title":"What role for recombinant human TSH in the treatment of metastatic thyroid cancer?","volume":"36","author":"Zanotti-Fregonara","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-13-20210226","first-page":"490","article-title":"Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy","volume":"53","author":"Molinaro","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R26-13-20210226","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00259-008-1013-9","article-title":"Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective","volume":"36","author":"Luster","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R27-13-20210226","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/thy.2007.0331","article-title":"Review on the occasion of a decade of recombinant human TSH: prospects and novel uses","volume":"18","author":"Duntas","year":"2008","journal-title":"Thyroid"},{"key":"R28-13-20210226","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.1977.tb06833.x","article-title":"Thyroid hormones stimulate erythropoiesis in vitro","volume":"37","author":"Golde","year":"1977","journal-title":"Br J Haematol"},{"key":"R29-13-20210226","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0883-2897(89)90188-8","article-title":"Comparison of bone marrow dosimetry and toxic effect of high dose 131I-labeled monoclonal antibodies administered to man","volume":"16","author":"Larson","year":"1989","journal-title":"Int J Rad Appl Instrum B"},{"key":"R30-13-20210226","first-page":"374","article-title":"Effect of low dose radiation on differentiation of bone marrow cells into dendritic cells","volume":"11","author":"Chun","year":"2012","journal-title":"Dose Response"},{"key":"R31-13-20210226","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0301-472X(02)00802-0","article-title":"Hematologic consequences of exposure to ionizing radiation","volume":"30","author":"Dainiak","year":"2002","journal-title":"Exp Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:30:30Z","timestamp":1620959430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201608300-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004451","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}